<DOC>
	<DOCNO>NCT01064570</DOCNO>
	<brief_summary>Prospective use RT-PCR PML/RARa might use guide total tehrapy approach APL , include refine diagnosis , front-line treatment , assessment response anticipate salvage therapy patient undergo molecular relapse .</brief_summary>
	<brief_title>AIDA 2000 Guidelines</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Promyelocytic , Acute</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Age &gt; = 1 year &lt; 61 year Morphologic diagnosis APL PS &lt; = 3 Presence leukemic cell diagnosis ( 15 ; 17 ) , and/or PML/RARa rearrangement RTPCR . T The presence additional cytogenetic lesion consider exclusion criterion Serum creatinine &lt; =2.5 mg/dL Serum bilirubin , alkaline phosphatase , GOT/ASAT &lt; = 3 time upper normal limit Negative pregnancy test Written inform consent Age &gt; = 61 year Prior antileukemic chemotherapy APL Absence PMLRARa rearrangement successful RNA extraction amplification control gene Prior antileikemic chemotherapy APL Presence concomitant malignant neoplasm , except basal cell carcinoma Concurrent treatment cytotoxic chemotherapy radiotherapy Oteher progressive malignant disease . However , secondary acute promyelocytic leukemia follow `` cure '' Hodgkin 's disease otehr cure malignancy may include , well secondary leukemia follow exposure alkylating agent radiation reason</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Acute Promyelocytic Leukemia</keyword>
	<keyword>APL</keyword>
</DOC>